Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Revolution Medicines (RVMD)
NASDAQ:RVMD
Revolution Medicines (RVMD) Stock Price & Analysis
182 Followers
RVMD Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$15.44 - $35.60
Previous Close$31.72
Volume1.04M
Average Volume (3M)1.37M
Market Cap
$5.22B
Enterprise Value$3.46B
Total Cash (Recent Filing)$1.85B
Total Debt (Recent Filing)$87.94M
Price to Earnings (P/E)-8.4
Beta1.43
Next Earnings
May 06, 2024EPS Estimate
-$0.75Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.77
Shares Outstanding164,690,408
10 Day Avg. Volume1,713,474
30 Day Avg. Volume1,373,263
Standard Deviation0.17
R-Squared0.24
Alpha-0.00660
Financial Highlights & Ratios
Price to Book (P/B)2.82
Price to Sales (P/S)451.12
Price to Cash Flow (P/CF)-10.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue298.70
Enterprise Value/Gross Profit298.70
Enterprise Value/Ebitda-7.58
Forecast
1Y Price Target
$38.57Price Target Upside19.67% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
Revolution Medicines News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
RVMD FAQ
What was Revolution Medicines’s price range in the past 12 months?
Revolution Medicines lowest stock price was $15.44 and its highest was $35.60 in the past 12 months.
What is Revolution Medicines’s market cap?
Currently, no data Available
When is Revolution Medicines’s upcoming earnings report date?
Revolution Medicines’s upcoming earnings report date is May 06, 2024 which is in 17 days.
How were Revolution Medicines’s earnings last quarter?
Revolution Medicines released its earnings results on Feb 26, 2024. The company reported -$1.14 earnings per share for the quarter, missing the consensus estimate of -$0.853 by -$0.287.
Is Revolution Medicines overvalued?
According to Wall Street analysts Revolution Medicines’s price is currently Undervalued.
Does Revolution Medicines pay dividends?
Revolution Medicines does not currently pay dividends.
What is Revolution Medicines’s EPS estimate?
Revolution Medicines’s EPS estimate is -$0.75.
How many shares outstanding does Revolution Medicines have?
Revolution Medicines has 164,690,410 shares outstanding.
What happened to Revolution Medicines’s price movement after its last earnings report?
Revolution Medicines reported an EPS of -$1.14 in its last earnings report, missing expectations of -$0.853. Following the earnings report the stock price went up 0.79%.
Which hedge fund is a major shareholder of Revolution Medicines?
Among the largest hedge funds holding Revolution Medicines’s share is Farallon Capital Management, L.L.C.. It holds Revolution Medicines’s shares valued at 193M.
---
Revolution Medicines Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$38.57 (19.67% Upside)
$38.57 (19.67% Upside)
Blogger Sentiment
Bullish
RVMD Sentiment 75%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 6.4M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.3%
Last 30 Days ▼ 6.5%
Last 30 Days ▼ 6.5%
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
43.40%
12-Months-Change
Fundamentals
Return on Equity
-34.75%
Trailing 12-Months
Asset Growth
149.18%
Trailing 12-Months
Company Description
Revolution Medicines
Revolution Medicines, Inc. is a clinical-stage precision oncology company focused on developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.
---
RVMD Earnings Call
Q4 2024
0:00 / 0:00
---
RVMD Stock 12 Months Forecast
Average Price Target
$38.57
▲(19.67% Upside)
Technical Analysis
Kura Oncology
―
Arvinas Holding Company
―
Arrowhead Pharmaceuticals
―
Corvus Pharmaceuticals
―
Best Analysts Covering RVMD
1 Year
1 Year Success Rate
8/8 ratings generated profit
1 Year Average Return
+20.21%
reiterated a buy rating 2 months ago
Copying Benjamin Burnett's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +20.21% per trade.
---